Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae

被引:63
|
作者
Lungu, AO
Jin, ZG
Yamawaki, H
Tanimoto, T
Wong, C
Berk, BC
机构
[1] Univ Rochester, Sch Med & Dent, Aab Inst Biomed Sci, Cardiovasc Res Ctr, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Aab Inst Biomed Sci, Dept Med, Rochester, NY 14642 USA
关键词
D O I
10.1074/jbc.M313897200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fluid shear stress generated by blood flowing over the endothelium is a major determinant of arterial tone, vascular remodeling, and atherogenesis. Nitric oxide (NO) produced by endothelial NO synthase (eNOS) plays an essential role in regulation of vascular function and structure by blood flow. Although cyclosporin A (CsA), an inhibitory ligand of cyclophilin A, is a widely used immunosuppressive drug, it causes arterial hypertension in part by impairing eNOS-dependent vasodilation. Here we show that CsA inhibits fluid shear stress-mediated eNOS activation in endothelial cells via decreasing cholesterol content in caveolae. Exposure of cultured bovine aortic endothelial cells to 1 muM CsA for 1 h significantly inhibited NO production and eNOS phosphorylation at Ser-1179 induced by flow (shear stress=12 dynes/cm(2)). The effect of CsA was not related to inhibition of two known eNOS kinases, protein kinase B (Akt) and protein kinase A, because CsA did not affect Akt or protein kinase A activation. In rabbit aorta perfused ex vivo, CsA also significantly inhibited flow-induced eNOS phosphorylation at Ser-1179 but had no effect on Akt measured by phosphorylation at Ser-473. However, CsA treatment decreased cholesterol content in caveolae and displaced eNOS from caveolae, which may be caused by CsA disrupting the association of caveolin-1 and cyclophilin A. The magnitude of the cholesterol depleting effect was similar to that of beta-cyclodextrin, a cholesterol-binding molecule, and beta-cyclodextrin had a similar inhibitory effect on flow-mediated eNOS activation. Treating bovine aortic endothelial cells for 24 h with 30 mug/ml cholesterol blocked the CsA effect and restored eNOS phosphorylation in response to flow. These data suggest that decreasing cholesterol content in caveolae by CsA is a potentially important pathogenic mechanism for CsA-induced endothelial dysfunction and hypertension.
引用
收藏
页码:48794 / 48800
页数:7
相关论文
共 50 条
  • [41] Bone Morphogenetic Protein Receptor II Is a Novel Mediator of Endothelial Nitric-oxide Synthase Activation
    Gangopahyay, Archana
    Oran, Max
    Bauer, Eileen M.
    Wertz, Jeffrey W.
    Comhair, Suzy A.
    Erzurum, Serpil C.
    Bauer, Philip M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (38) : 33134 - 33140
  • [42] IMMUNOVASCULAR COMMUNICATION - ACTIVATION AND DEACTIVATION OF MURINE ENDOTHELIAL-CELL NITRIC-OXIDE SYNTHASE BY CYTOKINES
    SCHNEEMANN, M
    SCHOEDON, G
    FREI, K
    SCHAFFNER, A
    IMMUNOLOGY LETTERS, 1993, 35 (02) : 159 - 162
  • [43] Cyclosporin A inhibits inducible nitric-oxide synthase [iNOS] induction and TNF-alpha release in human keratinocytes.
    Becherel, PA
    LeGoff, L
    Chosidow, O
    Frances, C
    Mossalayi, D
    Arock, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (05) : P47 - P47
  • [44] Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells
    Cheng, Kenneth K. Y.
    Lam, Karen S. L.
    Wang, Yu
    Huang, Yu
    Carling, David
    Wu, Donghai
    Wong, Chiwai
    Xu, Aimin
    DIABETES, 2007, 56 (05) : 1387 - 1394
  • [45] The Evaluation of Flow-Mediated Vasodilation in the Brachial Artery Correlates With Endothelial Dysfunction Evaluated by Nitric Oxide Synthase Metabolites in Marfan Syndrome Patients
    Lomeli, Oscar
    Perez-Torres, Israel
    Marquez, Ricardo
    Criales, Sergio
    Mejia, Ana M.
    Chiney, Claudia
    Hernandez-Lemus, Enrique
    Soto, Maria E.
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [46] Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo - Effect on agonist-induced and flow-mediated vascular responses
    Champion, HC
    Bivalacqua, TJ
    D'Souza, FM
    Ortiz, LA
    Jeter, JR
    Toyoda, K
    Heistad, DD
    Hyman, AL
    Kadowitz, PJ
    CIRCULATION RESEARCH, 1999, 84 (12) : 1422 - 1432
  • [47] Epoetin beta pegol ameliorates flow-mediated dilation with improving endothelial nitric oxide synthase coupling state in nonobese diabetic rats
    Serizawa, Kenichi
    Yogo, Kenji
    Tashiro, Yoshihito
    Kawasaki, Ryohei
    Endo, Koichi
    Shimonaka, Yasushi
    Hirata, Michinori
    CARDIOVASCULAR THERAPEUTICS, 2017, 35 (02)
  • [48] Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells
    Hung, Ming-Jui
    Cherng, Wen-Jin
    Hung, Ming-Yow
    Wu, Hsiao-Ting
    Pang, Jong-Hwei S.
    JOURNAL OF HYPERTENSION, 2010, 28 (05) : 940 - 951
  • [49] Flow-mediated dilation analysis coupled with nitric oxide transport to enhance the assessment of endothelial function
    Ma, Tianxiang
    Liu, Xiao
    Ren, Quan
    Zhang, Zhexi
    Sun, Xiaoning
    Zheng, Yuehong
    Deng, Xiaoyan
    Yu, Xiaojun
    Fan, Yubo
    JOURNAL OF APPLIED PHYSIOLOGY, 2021, 131 (01) : 1 - 14
  • [50] FLOW-MEDIATED VASODILATION IS NOT DEPENDENT UPON NITRIC-OXIDE PRODUCTION IN ISOLATED PORCINE CORONARY CONDUIT ARTERIES
    DUBE, S
    CANTY, JM
    CIRCULATION, 1995, 92 (08) : 3694 - 3694